Hims Tirzepatide: What It Is, What It Costs, and Whether You Can Still Get It

Hims tirzepatide is the compounded form of tirzepatide that Hims & Hers sold through its telehealth weight loss program. It uses the same active ingredient as Mounjaro and Zepbound, but it is not the brand-name drug and it is not FDA-approved as a finished product. Because federal rules tightened in 2024 and 2025, what the platform offers today depends on current regulation and on where you live.

What Hims Tirzepatide Actually Means

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Eli Lilly sells it as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management. Both are FDA-approved, prescription-only medicines.

Hims & Hers Health is a telehealth company, not a drug manufacturer. During the U.S. tirzepatide shortage, the company connected patients with licensed compounding pharmacies that mixed their own tirzepatide injections. That is what most people mean when they look up hims tirzepatide.

Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality the way it reviews brand-name medicines.

How the Hims & Hers Weight Loss Program Works

The program is built around an online intake rather than an in-person visit. The general steps look like this:

1. Complete a health questionnaire covering weight, medical history, and current medications.
2. A licensed provider reviews the intake and decides whether a GLP-1 medication is appropriate.
3. If approved, the prescription goes to a partner pharmacy, which ships the medication to your home.
4. You pay a monthly membership fee that bundles the medication with ongoing messaging support.
5. Dose increases are managed over time, often every four weeks, based on tolerance.

Medication arrives as a prefilled pen or a vial with clear dosing instructions. It is not a do-it-yourself kit. People who search how much bac water to reconstitute 20mg tirzepatide are usually looking at lyophilized research-grade vials, which is a completely different product category from a dispensed prescription.

Is Compounded Tirzepatide Still Available?

The FDA removed tirzepatide from its drug shortage list in late 2024 and gave compounding pharmacies deadlines in early 2025 to stop making copies of the drug. As a result, large-scale compounding of tirzepatide has largely ended, even though court challenges and shifting state rules created confusion along the way.

Compounding is still permitted in narrow situations, such as when a patient genuinely cannot take the approved product. Those exceptions are decided case by case, and they are not the same as a telehealth subscription that ships a compounded GLP-1 to anyone who qualifies by body mass index.

Availability varies by state, too. Some state boards have taken a stricter line than the FDA, and a pharmacy licensed in one state may not be allowed to ship into another.

Cost: Hims Tirzepatide vs. Brand-Name Options

Telehealth compounded GLP-1s have generally been cheaper than brand-name tirzepatide, which is the main reason people search for them. Prices change often, so treat the figures below as rough 2025 ranges and confirm current pricing directly with the seller.

Option	Active ingredient	FDA-approved?	Typical cash price
Zepbound injection pen	Tirzepatide	Yes	About $1,000 or more per month at list price
Zepbound single-dose vials (LillyDirect)	Tirzepatide	Yes	Roughly $349 to $499 per month
Compounded tirzepatide via telehealth	Tirzepatide	No	Roughly $299 to $399 per month
Compounded semaglutide via telehealth	Semaglutide	No	Roughly $99 to $299 per month

Insurance is another variable. Some commercial plans cover Zepbound for weight management, but prior authorization requirements are common, and compounded GLP-1s are almost never covered.

Side Effects and Safety Considerations

Tirzepatide's side effect profile is well documented in clinical trials of the brand-name product. Most issues are gastrointestinal and tend to ease after a few weeks.

Common side effects	Serious risks (rare)
Nausea, vomiting, diarrhea	Pancreatitis
Constipation, abdominal pain	Gallbladder disease
Burping, reflux, fatigue	Gastroparesis, or delayed stomach emptying
Injection-site reactions	Kidney injury from dehydration; low blood sugar with insulin or sulfonylureas

Brand-name tirzepatide carries a boxed warning about thyroid C-cell tumors observed in rodents. People with a personal or family history of medullary thyroid carcinoma or MEN2 should not use it.

Tirzepatide is not recommended during pregnancy or breastfeeding. Tell your prescriber about every medication and supplement you take, including anything purchased from an online peptide vendor.

Compounded versions add another layer of uncertainty, because potency and sterility are not verified by the FDA. Regulators have flagged dosing errors with compounded GLP-1s. Talk to a licensed healthcare professional before starting, stopping, or combining any weight-loss product.

Other Compounds People Mention Alongside Tirzepatide

Search interest in tirzepatide often spills over into molecules that are investigational, unapproved, or sold as research chemicals. None of the following are FDA-approved for weight loss, and none have been tested in human trials alongside tirzepatide.

• Cagrilintide. Cagrilintide is an amylin analog in late-stage trials, often paired with semaglutide. Comparisons such as cagrilintide vs tirzepatide pit an investigational amylin drug against an approved dual GIP/GLP-1 agonist, so the two are not interchangeable. A broader question like cagrilintide vs retatrutide vs tirzepatide involves two drugs that are not approved for weight loss at all.
• AOD-9604. AOD-9604 is a fragment of human growth hormone that failed to win regulatory approval for obesity. Reading about aod 9604 with tirzepatide means reading about two very different categories: an FDA-approved prescription and a research chemical with no human combination data.
• Lipo-C and B12 blends. Lipo-C is an injectable mix of B vitamins and lipotropic compounds sold by some clinics and med spas. The FDA has not approved it for weight loss, and pairing lipo-c and tirzepatide is not supported by clinical evidence.

Retatrutide, a triple agonist, is also in late-stage trials and is not approved. Buying any of these compounds from an online vendor means buying a product with no guarantee of purity, dose accuracy, or sterility.

Key Takeaways

• Hims tirzepatide was a compounded product, not FDA-approved brand-name Zepbound.
• Federal rules tightened after the tirzepatide shortage ended, and large-scale compounding has largely stopped.
• Compounded drugs are not reviewed by the FDA for safety, effectiveness, or potency.
• People with a history of medullary thyroid carcinoma, MEN2, pancreatitis, or pregnancy should discuss tirzepatide with a clinician first.
• GLP-1 medications support weight loss alongside diet and activity, and they are not a stand-alone fix.

Availability and pricing for Hims tirzepatide and similar telehealth programs change quickly, so verify current details on the company's site and review the risks with a licensed provider.

COMMON QUESTIONS

Frequently Asked Questions

Does Hims still offer tirzepatide?

Hims & Hers has wound down compounded tirzepatide as federal rules tightened, and its weight-loss lineup has changed several times since 2024. Whether a compounded GLP-1 can be dispensed at all depends on current FDA guidance and state law. Check the company's website for the offerings available in your state today.

Is compounded tirzepatide the same as Zepbound?

They share the same active ingredient, tirzepatide, but compounded versions are not FDA-approved and are not reviewed for potency, purity, or sterility. Zepbound has been evaluated in large randomized clinical trials that support its approval. Compounded copies have not gone through that process.

How much does Hims tirzepatide cost?

Compounded tirzepatide through telehealth platforms has typically run about $299 to $399 per month, which is well below Zepbound's list price. Membership terms and pricing change often, and insurance generally does not cover compounded GLP-1 medications. Confirm current pricing directly before enrolling.